tiprankstipranks
Medicus Pharma Ltd (MDCX)
NASDAQ:MDCX
US Market
MDCX
Medicus Pharma Ltd
RESEARCH TOOLSreports
Want to see MDCX full AI Analyst Report?

Medicus Pharma Ltd (MDCX) Stock News & Sentiment

266 Followers
Balancing Pipeline Potential and Funding Risk: Justifying a Buy Rating on Medicus Despite Extended Timelines
Premium
Ratings
Balancing Pipeline Potential and Funding Risk: Justifying a Buy Rating on Medicus Despite Extended Timelines
12d ago
MDCX
Medicus Pharma Expands ATM Equity Program for Funding
Premium
Company Announcements
Medicus Pharma Expands ATM Equity Program for Funding
12d ago
8K
MDCX
Medicus Pharma Showcases Long-Acting Teverelix Data, Targets Precision Endometriosis Therapy
Premium
Company Announcements
Medicus Pharma Showcases Long-Acting Teverelix Data, Targets Precision Endometriosis Therapy
21d ago
MDCX
Medicus Pharma Streamlines Phase 2 Teverelix Trial for $2 Billion AUR Market
Premium
Company Announcements
Medicus Pharma Streamlines Phase 2 Teverelix Trial for $2 Billion AUR Market
1M ago
MDCX
Medicus Pharma Sharpens SkinJect Phase 2 Narrative, Pivots to 200µg Dose for Registrational Path
Premium
Company Announcements
Medicus Pharma Sharpens SkinJect Phase 2 Narrative, Pivots to 200µg Dose for Registrational Path
1M ago
MDCX
Medicus Pharma’s SkinJect Phase 2 Data Validated by KOL With 80% Response Rate
Premium
Company Announcements
Medicus Pharma’s SkinJect Phase 2 Data Validated by KOL With 80% Response Rate
1M ago
MDCX
Medicus Pharma’s SkinJect Data Earns KOL Validation With 80% Response in Phase 2
Premium
Company Announcements
Medicus Pharma’s SkinJect Data Earns KOL Validation With 80% Response in Phase 2
1M ago
MDCX
More MDCX News >

MDCX News on the Web

Medicus Pharma seeks orphan drug status for SkinJect in rare skin cancer disorder
Proactive Investors
Bullish
Medicus Pharma Targets Unmet Need with Orphan Drug Application for SkinJect in Gorlin Syndrome
Market Chameleon
Neutral
Medicus Pharma submits ODD application to U.S. FDA for SkinJect
TipRanks News
Bullish
Medicus Pharma Showcases Long-Acting Teverelix Data, Targets Precision Endometriosis Therapy
TipRanks News
Neutral
Medicus Pharma to present new Teverelix data at upcoming endocrinology meeting
Proactive Investors
Neutral
Medicus Pharma gives Teverelix Phase 2 FDA update – ICYMI
Proactive Investors
Bullish
Medicus Pharma enters media partnership with New to The Street
TipRanks News
Neutral
Medicus Pharma Streamlines Phase 2 Teverelix Trial for $2 Billion AUR Market
TipRanks News
Bearish

News Score - Last 7 Days

Positive
MDCX
Sector Average
Media Buzz
This Week5 articles
Weekly Average5.75 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MDCX’s Media Buzz Sentiment?
5 articles about MDCX were published this week. In an average week, 5.75 articles are published.
    What is MDCX’s weekly average amount of articles?
    In an average week, 5.75 articles about MDCX are published.
      What is MDCX’s News Sentiment?
      100% of articles about MDCX were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week